FLGT.NASDAQFulgent Genetics, INC

Form 4: Fulgent Genetics CFO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Fulgent Genetics, INC
🔒Login to Follow

Fulgent Genetics CFO Paul Kim disposed of 1,166 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Summary

  • Paul Kim, the Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported a transaction involving company common stock.
  • On August 26, 2025, Mr. Kim disposed of 1,166 shares of common stock at a price of $21.47 per share.
  • This transaction was identified by transaction code 'F', indicating shares were withheld to satisfy tax withholding obligations.
  • The tax obligations arose from the vesting of restricted stock units (RSUs) granted to Mr. Kim on February 26, 2024.
  • Following this transaction, Mr. Kim directly beneficially owns 337,992 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate a positive or negative sentiment towards the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: This is a routine, non-discretionary transaction and is unlikely to have a significant impact on shareholder sentiment or the company's valuation.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
02/26/2024Date restricted stock units (RSUs) were granted to Paul Kim.
08/26/2025Date of the reported transaction where shares were disposed of for tax withholding.
08/28/2025Date the Form 4 filing was signed by Paul Kim.

Recommendation

hold

The filing details a routine insider transaction where the CFO disposed of shares to cover tax obligations upon RSU vesting. This is a common and expected event and does not reflect a change in the company's fundamentals or the insider's long-term view, thus warranting a 'hold' recommendation.

Keywords

Fulgent Genetics, FLGT, Paul Kim, CFO, Insider Transaction, Form 4, Stock Sale, RSU Vesting, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.